Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

NEAR Protocol Price Predictions: Where Will the NEAR Crypto Go After Record Highs?

Given the increased interest around NEAR Protocol, investors may be intrigued to know the NEAR Protocol price predictions for this token.

HOTH Stock Alert: Why Is Hoth Therapeutics Skyrocketing Today?

Investors in Hoth Therapeutics and HOTH stock have seen their investment go parabolic today on a key update for one of the company's drugs.

NAKD Stock Alert: What Is Going on With Naked Brand Today?

Today, NAKD stock is once again losing altitude, despite a near-term catalyst many investors have their eye on with this small-cap stock.

Dear SHIB Crypto Fans, a New DAO Catalyst Is Coming for Shiba Inu

The adoption of a new decentralized autonomous organization (DAO) structure has some investors in the SHIB crypto excited today.

NVAX Stock Alert: What Is Going on With Novavax Today?

Here's what's driving the price performance in Novavax and NVAX stock right now, as the stock sinks 4% today on a lower-volume day.